US2358511028 - Common Stock
Bill Gates is undoubtedly interested in AI stocks to buy. Here are three of his foundation’s current holdings.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.
Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday,...
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen...
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets...
Danaher (DHR) declares $0.27/share quarterly dividend, 12.5% increase from prior dividend of $0.24. Forward yield 0.43% Payable April 26; for shareholders of re
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share...
/PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, today launched a strategic collaboration with Cincinnati Children's...
Danaher (DHR) projects narrowing topline in 2024 due to drop in demand for COVID-related products. Despite Q4 beat, its revenue dropped 11% YoY in 2023. Read more here.
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2023. All results in this release...
U.S. life sciences toolmakers Danaher (DHR), Repligen (REGN), and Bio-Rad (BIO) see gains as German peer Sartorius (SARTF) posts strong Q4 2023 results. Read more here.
Barclays downgrades Thermo Fisher Scientific (TMO) and Danaher (DHR) citing limited room for upside after recent surge in stock prices. REad more here.
Barclays downgrades Thermo Fisher Scientific (TMO) and Danaher (DHR) citing limited room for upside after recent surge in stock prices. REad more here.
alfexe Buckle up for the next chapter of earnings season.